株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
年間契約型情報サービス

癌の薬剤・伝達経路アナライザー:デスクトップアプリ

Oncology Drug Pathway Analyzer - Desktop App

発行 BioSeeker Group AB 商品コード 243231
出版日 年間契約型情報サービス ページ情報 英文
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
癌の薬剤・伝達経路アナライザー:デスクトップアプリ Oncology Drug Pathway Analyzer - Desktop App
出版日: 年間契約型情報サービス ページ情報: 英文
概要

当ソフトウェアアプリケーションは、約90種の癌症例における薬剤および伝達経路の関係性を解析するためのインタラクティブなハイレベルデータツールであり、単一経路および複数経路のクロストークの検証や適応症、ステージ、企業、分子機能など12項目のパラメーターによるフィルタリングなどを行うことが可能です。本プレミアム版アナライザーでは、以下の内容を提供いたします。

プレミアム版アナライザー

  • 単一経路および複数経路間のクロストークの検証
  • 各種パラメーターからの結果のフィルタリング
  • 特定の経路をターゲットとしている競合企業の数および企業名の特定
  • 特定の経路をターゲットとしている薬剤の数・名称・状況の特定
  • 詳細な経路情報・企業情報のリンクアウト対応コンテンツ
  • チャート・グラフ
  • 各薬剤の標的・開発プロジェクトの情報
  • PDFプリントに対応
  • ダイナミックレポート生成機能による3,000種近い薬剤の詳細プロファイルレポート
目次

Get instant, interactive pathway modeling on more than 3,800 cancer drugs across more than 100 different cancer types.

Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer. This highly unique interactive tool is based on BioSeeker's linking of hundreds of drug targets in many different types of cancer to a wide array of pathways. The included drugs are all from early stage development to market in maturity; also featuring ceased and suspended drugs.

The Oncology Drug Pathway Analyzer is an interactive high level data tool to analyze several thousand drug-pathway connections in more than 100 different cancer indications on the fly. The tool lets you examine both single pathways and crosstalk between pathways of drugs and filter the included drugs per pathway by twelve drug specific parameters (i.e. Indication, Stage, Company, Molecular function etc.).

The Oncology Drug Pathway Analyzer is a great facilitator to realize your position and options in drug development when utilizing pathways and it significantly cuts the amount of time it takes to do so.

The following short video playlist demonstrates the use of the Pathway Analyzer when you know what pathways you are interested in, when you are unsure of which pathways you should be interested in and when you want to compare pathways. It also details what you can expect from a drug profile result.

VIDEO DEMONSTRATION

Read more below on how to bring out the power in your pipeline and start to quickly analyze the impact of emerging pathway data in cancer by getting your own version of the Oncology Drug Pathway Analyzer.

Why you should use this tool:

  • Map the competition and find suitable benchmarking drugs based on specific pathways and drug properties
  • Reveal repositioning opportunities for your older, shelved drugs
  • Evaluate the progression and success of targeting certain pathways for the treatment of cancer
  • Investigate drugs which affect crosstalk between key pathways
  • Investigate different combination therapy options available to you in various cancer types. Use this tool to look for the most-efficient ways to combine your drug with other targeted agents.
  • Find possible adjuvant therapy settings with other drugs

Real case scenario (combination therapy):

In the March 20, 2012 issue of the journal Cancer Cell, researchers at The University of Texas MD Anderson Cancer Center reveal that the mTOR molecular pathway stimulates the activity of the Gli1 protein in the development and progression of esophageal cancer. Hitherto it is known that the Hedgehog pathway is the established pathway for activating Gli1. In experiments the researchers then went on to show that a combination of the mTOR inhibitor everolimus (Afinitor) and the Hedgehog inhibitor vismodegib (Erivedge) steeply reduced the tumor burden in a mouse model of esophageal adenocarcinoma.

Our tool would in seconds let you know how many and which drug are available for potential drug combination therapies in affecting both the Hedgehog- and the mTOR pathway. It also would instantly tell you which drugs is available affecting both pathways. You could then further refine the results by up to eleven drug specific parameters (i.e. Indication, Stage, Company, Molecular function etc.). There after you can view in-depth progress reports on each of the drugs of interest to you.

Back to Top